Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ritlecitinib helps adolescents with severe alopecia areata regrow scalp hair and normalize body hair and nails.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib effectively regrows hair in treatment-resistant alopecia areata with mild side effects.

A woman's hair turned white after taking a cancer drug called dasatinib.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Erlotinib can cause hair loss as a side effect.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.